+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Foot & Mouth Disease Vaccines Market - Global Forecast 2025-2030- Product Image
Foot & Mouth Disease Vaccines Market - Global Forecast 2025-2030- Product Image
Sale

Foot & Mouth Disease Vaccines Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829815
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Foot & Mouth Disease Vaccines Market offers a critical foundation for livestock health management, enabling agricultural enterprises and policy leaders to mitigate disease risk, ensure production continuity, and protect trading interests globally. As evolving threats challenge established protocols, strategic immunization emerges as a decisive factor for operational resilience and sector sustainability.

Market Snapshot: Foot & Mouth Disease Vaccines Market Overview

The Foot & Mouth Disease Vaccines Market grew from USD 2.93 billion in 2024 to USD 3.21 billion in 2025. It is expected to continue growing at a CAGR of 9.13%, reaching USD 4.96 billion by 2030. This growth reflects intensifying biosecurity demands, rising global livestock populations, and accelerating government interventions—factors driving adoption across developed and emerging regions. Recent adoption of innovative vaccine platforms and broadening regulatory collaboration further amplify the industry’s trajectory. Stakeholders are responding to dynamic disease patterns, cost pressures, and evolving trade requirements by investing in agile vaccine strategies designed to support both preventive and rapid response initiatives.

Scope & Segmentation of the Foot & Mouth Disease Vaccines Market

This report defines the full spectrum of market segmentation, spanning core product types, end users, and key distribution regions:

  • Animal Types: Bovine, sheep, goat, and swine populations are the primary vaccine recipients, each demanding unique formulation and administration schedules based on susceptibility and sector roles.
  • Vaccine Types: Inactivated vaccines remain widely adopted for mass campaigns; live attenuated vaccines offer targeted seroconversion; subunit vaccines focus on advanced safety and production precision.
  • Formulation Strategies: Includes monovalent and polyvalent options—such as bivalent, trivalent, and quadrivalent solutions—to address local strain variability.
  • End Users: Veterinary clinics, hospitals, and research institutes serve as principal channels for administration, R&D, and outbreak mitigation.
  • Route of Administration: Injection dominates large farm operations, while oral delivery increases coverage in extensive or remote livestock settings.
  • Applications: Preventive immunization drives and therapeutic interventions during outbreaks are both key drivers of demand.
  • Distribution Channels: Offline distribution covers department stores, direct sales, and specialty outlets; online channels include company websites and e-commerce platforms, supporting efficient central procurement.
  • Geographic Coverage: Americas (including the United States by state, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (with detailed country-level granularity); Asia-Pacific (covering major economies and regional livestock hubs).
  • Technology Platforms: The sector utilizes traditional inactivated and live platforms, next generation approaches like mRNA and virus-like particles, enhanced adjuvant systems, digital cold chain management, and modular manufacturing concepts.
  • Key Companies: Market analysis includes Merck & Co., Boehringer Ingelheim, Zoetis, Ceva Santé Animale, Indian Immunologicals, Laboratorios Hipra, Brilliant Bio Pharma, Biogénesis Bagó, and others.

Key Takeaways for Senior Decision-Makers

  • Continuous innovation in vaccine technology—such as DIVA (Differentiating Infected from Vaccinated Animals) platforms—streamlines outbreak response and facilitates continuity of international trade.
  • Collaborative frameworks between governments, biotech firms, and regulators accelerate response timelines and enable faster field deployment of new formulations where needed.
  • Cold chain logistics remain a strategic priority; digital tracking and predictive analytics are now widely used to reduce spoilage and strengthen delivery reliability.
  • Shift toward polyvalent and thermostable vaccines aligns with demands from diverse regional markets, addressing both endemic strain coverage and infrastructure limitations.
  • Online and offline procurement models co-exist to accommodate the full range of purchasing behaviors, from bulk strategic sourcing to targeted last-mile supply for remote end users.
  • Ongoing scenario planning and real-time data integration equip organizations to pivot rapidly in response to regulatory, epidemiological, or supply chain fluctuations.

Tariff Impact and Supply Chain Adaptation

Recent adjustments to United States tariffs have notably influenced input cost structures in the vaccine supply chain. Manufacturers are reassessing sourcing and procurement to mitigate increased expenses for specialized adjuvants and packaging materials. Many companies have diversified production footprints and sought exemptions for pandemic-relevant supplies. The resulting environment raises the importance of scenario planning and flexible supply structures to maintain vaccine accessibility worldwide.

Methodology & Data Sources

This research applies a robust methodology, integrating in-depth primary interviews, secondary data review, and rigorous analytical frameworks. Qualitative insights are cross-validated with industry data, published studies, and expert peer review, establishing a resilient foundation for actionable conclusions.

Why This Report Matters

  • Enables strategic planning by providing clear, actionable intelligence on market dynamics, emerging technologies, and regulatory changes.
  • Supports optimized decision-making with segmented insights tailored to roles, regional conditions, and evolving risk landscapes.
  • Assists in identifying new procurement opportunities, competitive benchmarks, and effective collaboration models for robust disease management strategies.

Conclusion

The Foot & Mouth Disease Vaccines Market is defined by rapid innovation, adaptive supply chains, and engaged cross-sector collaboration. Leveraging these elements will be central to building resilient livestock health infrastructure and securing long-term agricultural sustainability.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of thermostable FMD vaccines reduces cold chain dependency in sub-Saharan Africa
5.2. Integration of mRNA-based platforms for rapid FMD vaccine design accelerates outbreak response capabilities
5.3. Implementation of novel DIVA-compatible FMD vaccines facilitates serological differentiation in endemic regions
5.4. Government incentives and public-private partnerships drive large-scale FMD vaccine manufacturing capacity expansion
5.5. Advancement in nanoparticle adjuvant technology enhances immunogenicity of FMD vaccines in cattle
5.6. Emerging demand for single-dose recombinant FMD vaccines improves farm-level biosecurity measures
5.7. Scaling up of region-specific bivalent FMD vaccine strains addresses diverse serotype circulation risks
5.8. Regulatory harmonization efforts across regional trade blocs accelerate cross-border FMD vaccine approvals
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Foot & Mouth Disease Vaccines Market, by Animal Type
8.1. Introduction
8.2. Bovine
8.3. Sheep And Goat
8.4. Swine
9. Foot & Mouth Disease Vaccines Market, by Vaccine Type
9.1. Introduction
9.2. Inactivated Vaccine
9.3. Live Attenuated Vaccine
9.4. Subunit Vaccine
10. Foot & Mouth Disease Vaccines Market, by Formulation
10.1. Introduction
10.2. Monovalent
10.3. Polyvalent
10.3.1. Bivalent
10.3.2. Quadrivalent
10.3.3. Trivalent
11. Foot & Mouth Disease Vaccines Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
11.4. Research Institutes
12. Foot & Mouth Disease Vaccines Market, by Route Of Administration
12.1. Introduction
12.2. Injection
12.3. Oral
13. Foot & Mouth Disease Vaccines Market, by Application
13.1. Introduction
13.2. Preventive
13.3. Therapeutic
14. Foot & Mouth Disease Vaccines Market, by Distribution Channel
14.1. Introduction
14.2. Offline
14.2.1. Department Stores
14.2.2. Direct Sales
14.2.3. Specialty Stores
14.3. Online
14.3.1. Company Websites
14.3.2. E-commerce Platforms
15. Americas Foot & Mouth Disease Vaccines Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Foot & Mouth Disease Vaccines Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Foot & Mouth Disease Vaccines Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Merck & Co., Inc.
18.3.2. Boehringer Ingelheim International GmbH
18.3.3. Zoetis Inc.
18.3.4. Ceva Santé Animale S.A.
18.3.5. Indian Immunologicals Limited
18.3.6. Laboratorios Hipra, S.A.
18.3.7. Vetal Animal Healh Products S.A.
18.3.8. Indian Immunologicals Ltd
18.3.9. Brilliant Bio Pharma Ltd.
18.3.10. Biogénesis Bagó S.A.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. FOOT & MOUTH DISEASE VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. FOOT & MOUTH DISEASE VACCINES MARKET: RESEARCHAI
FIGURE 30. FOOT & MOUTH DISEASE VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 31. FOOT & MOUTH DISEASE VACCINES MARKET: RESEARCHCONTACTS
FIGURE 32. FOOT & MOUTH DISEASE VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FOOT & MOUTH DISEASE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY BIVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY BIVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY QUADRIVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY QUADRIVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TRIVALENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TRIVALENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PREVENTIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DEPARTMENT STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DEPARTMENT STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 123. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 130. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 131. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 140. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 141. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 142. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 150. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 151. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 248. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 252. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 253. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 266. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 272. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 273. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 282. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 283. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 284. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY POLYVALENT, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 305. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 306. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 307. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 310. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY FORMULATION, 2025-2030 (USD M

Samples

Loading
LOADING...

Companies Mentioned

  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Ceva Santé Animale S.A.
  • Indian Immunologicals Limited
  • Laboratorios Hipra, S.A.
  • Vetal Animal Healh Products S.A.
  • Indian Immunologicals Ltd
  • Brilliant Bio Pharma Ltd.
  • Biogénesis Bagó S.A.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.96 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Foot and Mouth Disease Vaccine Market Size, Share and Trends Analysis Report by Animal (Cattle, Sheep & Goat, Swine), Vaccine (Modified/Attenuated Live), Distribution Channel, and Region 2024-2030 - Product Image

Foot and Mouth Disease Vaccine Market Size, Share and Trends Analysis Report by Animal (Cattle, Sheep & Goat, Swine), Vaccine (Modified/Attenuated Live), Distribution Channel, and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Foot And Mouth Disease Vaccine Global Market Report 2025 - Product Image

Foot And Mouth Disease Vaccine Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Swine Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Swine Vaccines - Global Strategic Business Report - Product Image

Swine Vaccines - Global Strategic Business Report

  • Report
  • 398 Pages
  • Global
From
Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Modified/Attenuated Live), By Type (Pseudorabies, Porcine Circovirus Type 2), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Modified/Attenuated Live), By Type (Pseudorabies, Porcine Circovirus Type 2), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Foot and Mouth Disease Vaccines Market

The Foot and Mouth Disease (FMD) Vaccines market is a segment of the Animal Pharmaceuticals industry. FMD is a highly contagious viral disease that affects cloven-hoofed animals, such as cattle, sheep, goats, and pigs. Vaccines are used to protect animals from the disease, and the FMD Vaccines market is composed of companies that produce and distribute these vaccines. Vaccines are typically administered through injection, and may be used to prevent outbreaks or to control existing outbreaks. The FMD Vaccines market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Sante Animale. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.